| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO, Chairman | EVP and Chief Strategy Officer
1 company
Lance Alstodt last filed a Form 4 in October 2025, as President, CEO, Chairman at BRTX. From August 2019 to October 2025, the filings on record show 33 open-market purchases and 0 sales. Lance Alstodt's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Lance Alstodt's trades have earned a middling insider score of 55/100 across 29 rated trades. Over a 12-month horizon, 37.9% of those trades were profitable, with an average 12-month return of -10.2%.
At the last filing, the largest reported position was 187,497 shares of BRTX. Net of sales, the BRTX filings show accumulation of 83,552 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 1,800 | $2.99 | $5,374.98 | +1.0% | +9.9% | -38.9% | |
| Nov 18, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 1,000 | $2.88 | $2,876.50 | +0.5% | +3.9% | -33.6% | |
| Sep 22, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 200 | $2.92 | $584.00 | +0.1% | +2.5% | -41.7% | |
| Jul 12, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 700 | $2.95 | $2,065.00 | +0.4% | +16.1% | +3.7% | |
| Jun 30, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 1,100 | $3.10 | $3,407.91 | +0.6% | -4.1% | +49.5% | |
| Jun 16, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 600 | $3.73 | $2,238.00 | +0.3% | -12.9% | +72.2% | |
| Jun 15, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 700 | $3.68 | $2,577.54 | +0.4% | -13.9% | +55.7% | |
| Jun 14, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 500 | $3.91 | $1,955.95 | +0.3% | -12.3% | +45.7% | |
| Jun 13, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 200 | $3.95 | $790.00 | +0.1% | -16.1% | +36.1% | |
| Jun 8, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 100 | $4.28 | $428.00 | - | -25.1% | +23.5% |